| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 2.279 | 33.676 | 52.311 | 115.626 | 107.739 | 169.014 | 262.953 | 233.242 | 320.696 | 296.034 |
| Total Income - EUR | 3.072 | 33.955 | 53.096 | 119.370 | 110.131 | 171.268 | 265.214 | 237.892 | 327.179 | 300.123 |
| Total Expenses - EUR | 3.384 | 27.944 | 45.778 | 106.091 | 96.644 | 146.480 | 230.994 | 206.664 | 282.692 | 259.372 |
| Gross Profit/Loss - EUR | -312 | 6.010 | 7.318 | 13.279 | 13.488 | 24.789 | 34.219 | 31.228 | 44.486 | 40.751 |
| Net Profit/Loss - EUR | -380 | 5.336 | 6.790 | 12.118 | 12.417 | 23.336 | 31.638 | 29.239 | 41.990 | 35.067 |
| Employees | 1 | 1 | 1 | 3 | 2 | 1 | 2 | 2 | 2 | 4 |
Check the financial reports for the company - Tonik Pharm Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 196 | 0 | 0 | 0 | 0 | 0 | 22 | 3.851 | 78.406 | 92.285 |
| Current Assets | 7.134 | 15.344 | 23.208 | 37.180 | 30.090 | 56.743 | 92.262 | 94.806 | 90.732 | 99.417 |
| Inventories | 4.961 | 7.092 | 11.303 | 16.329 | 9.967 | 21.027 | 37.875 | 39.217 | 47.577 | 74.057 |
| Receivables | 1.444 | 5.064 | 5.839 | 8.356 | 7.495 | 20.189 | 12.531 | 10.571 | 26.695 | 21.525 |
| Cash | 729 | 3.189 | 6.066 | 12.495 | 12.628 | 15.526 | 41.856 | 45.017 | 16.460 | 3.835 |
| Shareholders Funds | -335 | 5.004 | 11.710 | 23.613 | 23.689 | 34.395 | 42.452 | 71.822 | 113.594 | 131.070 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 7.666 | 10.340 | 11.498 | 13.568 | 6.400 | 22.348 | 49.833 | 26.834 | 55.545 | 60.632 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8292 - 8292" | |||||||||
| CAEN Financial Year |
8292
|
|||||||||
Comments - Tonik Pharm Srl